The Parathyroid Hormone Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global parathyroid hormone market has been experiencing a steady increase lately. The market value is projected to rise from $2.35 billion in 2024 to $2.43 billion in 2025, signifying a Compound Annual Growth Rate (CAGR) of 3.5%.
The Parathyroid Hormone Global Market Report forecasts that by 2029, the market size will reach $3.5 billion, growing at a Compound Annual Growth Rate (CAGR) of 9.6%.
Download Your Free Sample of the 2025 Parathyroid Hormone Market Report and Uncover Key Trends Now!The key drivers in the parathyroid hormone market are:
• Rising geriatric population
• Expansion of private healthcare sectors
• Increase in precision medicine and emerging indications
• Growing awareness about bone health and expanding healthcare access
The parathyroid hormone market covered in this report is segmented –
1) By Disease Type: Hypocalcemia, Hypoparathyroidism
2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues
3) By End-User: Hospitals, Clinics, Other End-Users
The key trends in the parathyroid hormone market are:
• Advance trends in parathyroid hormone testing are becoming increasingly prevalent.
• The development in drug delivery mechanisms are shaping the future market.
• Combination therapies are emerging as a new trend in the sector.
• The integration of digital health and sustainability initiatives are becoming more significant.
Major companies in the parathyroid hormone market are:
• Pfizer Inc.
• Eli Lilly and Company
• Radius Health Inc.
• Ascendis Pharma
• Entera Bio Ltd.
• Extend Biosciences Inc.
• Gedeon Richter Plc.
• Abbott Laboratories
• Amgen Inc.
• Merck & Co. Inc.
• Novartis AG
• F. Hoffmann-La Roche AG
• Teva Pharmaceutical Industries Ltd.
• Alcon Laboratories Inc.
• Bayer Healthcare
• AstraZeneca PLC
• Biocon
• Dr. Reddy's Laboratories
• Glenmark Pharmaceuticals
• Jubilant Life Sciences
• Lupin Limited
• Sun Pharmaceutical Industries
• Torrent Pharmaceuticals
• Wockhardt
• Cipla Limited
The countries covered in the parathyroid hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada